Thierry Bilbault
About Thierry Bilbault
Thierry Bilbault serves as the Senior Vice President of Technical Operations at Ardelyx, Inc. He has over 20 years of experience in drug commercialization and has held various leadership roles in prominent pharmaceutical companies.
Current Role at Ardelyx
Thierry Bilbault serves as the Senior Vice President of Technical Operations at Ardelyx, Inc. since 2023. His role is based in Waltham, Massachusetts, and operates remotely. In this position, he oversees various technical operations, contributing to the company's mission in the pharmaceutical sector.
Previous Experience in Pharmaceutical Companies
Bilbault has extensive experience in the pharmaceutical industry. He worked at Akebia Therapeutics as Senior VP of Manufacturing and Pharmaceutical Development from 2021 to 2023. Prior to that, he held several significant roles, including Director of Global Manufacturing Services at Pfizer Global Manufacturing from 2004 to 2006, and VP of Global Product Development and Technology at Novartis Consumer from 2007 to 2009.
Educational Background and Qualifications
Thierry Bilbault studied at CUST Engineering Clermont Ferrand, where he earned a Master of Science in Biological Engineering from 1976 to 1980. He furthered his education at Université Blaise Pascal (Clermont-II), obtaining a Ph.D. in Molecular and Cellular Biology from 1980 to 1986. His educational background supports his expertise in drug delivery systems.
Expertise in Drug Delivery Systems
Bilbault specializes in the technology screening and evaluation of drug delivery systems, focusing on semi-solids, transdermal, and various dosage forms. He has a strong background in creating and optimizing drug delivery processes, emphasizing innovation, development, and transfer. His skills include managing global programs and leading technology transfer and development teams.
Career Milestones and Contributions
Throughout his career, Thierry Bilbault has accumulated over 20 years of experience in the commercialization of innovative drugs, medical devices, and cosmetic products. He has held leadership positions at Sunovion Pharmaceuticals, where he was Head of CMC Sublingual Apomorphine from 2016 to 2021 and Head of Technical Operations from 2017 to 2021. His roles have involved articulating and executing programs with various stakeholders, including business, R&D, and manufacturing.